Skip to main content
. 2021 Mar 18;21(1):16–29. doi: 10.5230/jgc.2021.21.e3

Table 3. Pathological data of 358 patients who underwent D1+/D2 radical gastrectomy.

Parameter All patients (358 patients) POPF (20 patients) No POPF (338 patients) P-value
Macroscopic type 0.484*
Mass (type 1) 39 (10.9) 1 (5.0) 38 (11.2)
Ulcerative (type 2) 118 (33.0) 9 (45.0) 109 (32.2)
Infiltrative-ulcerative (type 3) 171 (47.8) 9 (45.0) 162 (47.9)
Diffuse-infiltrative (type 4) 27 (7.5) 0 (0.0) 27 (8.0)
NA 2 (0.8) 1 (5.0) 1 (0.7)
Tumor diameter (cm) 5.6±3.2 6.3±4.5 5.6±3.1 0.649
Adenocarcinoma 311 (86.9) 18 (90.0) 293 (86.7) 1*
Lymphoma 28 (7.8) 1 (5.0) 27 (8.0) 1*
Grade of differentiation 1*
G1 85 (23.7) 4 (20.0) 81 (24.0)
G2 95 (26.5) 8 (40.0) 87 (25.7)
G3 124 (34.6) 4 (20.0) 120 (35.5)
NA 54 (15.2) 4 (20.0) 50 (14.8)
T stage 1*
T1 20 (5.6) 1 (5.0) 19 (5.6)
T2 70 (19.6) 4 (20.0) 66 (19.5)
T3 162 (45.3) 7 (35.0) 155 (45.9)
T4 82 (22.9) 6 (30.0) 76 (22.5)
NA 24 (6.6) 2 (10.0) 22 (6.5)
Positive lymph nodes 224 (62.6) 15 (75.0) 209 (61.8) 0.337*
No. of harvested lymph nodes 25±12 24.6±12 25.2±12 0.967
TNM stage 0.090*
Stage IA 16 (4.5) 1 (5.0) 15 (4.4)
Stage IB 41 (11.5) 2 (10.0) 39 (11.5)
Stage IIA 65 (18.2) 1 (5.0) 64 (18.9)
Stage IIB 59 (16.5) 2 (10.0) 57 (16.9)
Stage IIIA 54 (15.1) 5 (25.0) 49 (14.5)
Stage IIIB 59 (16.5) 2 (10.0) 57 (16.9)
Stage IIIC 38 (10.6) 5 (25.0) 33 (9.8)
Stage IV 5 (1.4) 0 (0.0) 5 (1.5)
NA 21 (5.7) 2 (10.0) 19 (5.6)
Negative resection margins 317 (88.5) 16 (80.0) 301 (89.0) 0.266*

Data are shown as mean±standard deviation or number (%).

POPF = postoperative pancreatic fistula, NA = not applicable.

*Fisher's exact test (2-tailed); Mann-Whitney U test (2-tailed).